Cash and marketable securities held in trust account
2,952,818
2,844,967
3,087,211
Total assets
3,094,757
3,030,741
3,184,756
Accounts payable and accrued liabilities
3,374,772
3,302,485
3,270,826
Income tax payable
40,096
51,596
141,000
Excise tax payable
189,163
189,163
187,240
Related party payables
488,965
493,965
463,965
Extension note, related party
2,220,000
2,130,000
2,040,000
Promissory note, related party
1,857,766
1,830,242
1,687,932
Total current liabilities
8,170,762
7,997,451
7,790,963
Deferred underwriting commissions
4,025,000
4,025,000
4,025,000
Total liabilities
12,195,762
12,022,451
11,815,963
Common stock subject to possible redemption 205,950 and 220,036 shares outstanding at redemption values of 14.81 and 14.47 per share as of june 30, 2026 and december 31, 2025, respectively
3,050,254
2,942,403
3,184,646
Common stock, par value 0.0001, 100,000,000 shares authorized 2,875,000 issued and outstanding (excluding 205,950 and 220,036 shares subject to possible redemption as of june 30, 2026 and december 31, 2025, respectively)
288
288
288
Accumulated deficit
-12,151,547
-11,934,401
-11,816,141
Total stockholders deficit
-12,151,259
-11,934,113
-11,815,853
Total liabilities and stockholders deficit
3,094,757
3,030,741
3,184,756
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Time Plot
Show the time plot by selecting a row from the table.